Negative-type electroretinogram from cisplatin toxicity

Doc Ophthalmol. 1993;84(3):237-46. doi: 10.1007/BF01203656.

Abstract

A 68-year-old woman with ovarian cancer suffered a loss of visual acuity and color perception after inadvertent overdosage with the antineoplastic agent cisplatin. Her acuity returned to normal but a tritan color defect persisted more than a year later. Her electroretinogram was stable between 7 weeks and 15 months after cisplatin administration, with a negative-type scotopic response, but also reduced cone b waves and a loss of some scotopic oscillatory potentials. With light stimuli between 10 and 100 ms in duration, the photopic on-responses were markedly reduced while the off-responses were normal or close to it. This case suggests that cisplatin may selectively injure on-pathways in the retina and indicates the need to expand the list of disorders that may cause a negative-type electroretinogram.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Cisplatin / poisoning*
  • Cisplatin / therapeutic use
  • Color Vision Defects / chemically induced
  • Color Vision Defects / physiopathology
  • Drug Overdose
  • Electroretinography / drug effects
  • Female
  • Humans
  • Ovarian Neoplasms / drug therapy
  • Retina / drug effects*
  • Retina / physiology
  • Visual Acuity / drug effects

Substances

  • Cisplatin